Skip to main content
Sign In
 


​The faculty of the Division of Hematology are responsible for teaching, clinical care and research in all aspects of Hematologic Disorders.  Our division has physicians and mid-level providers who are devoted primarily to clinical care and clinical research, physician scientists who divide their time between the lab and the clinic and scientists who spend their time focused primarily on laboratory research.  Because we take such an integrated approach to the diagnosis, treatment and curing of blood disorders we are able to move treatments from the bench to the bedside in a significantly more timely fashion.  Our patients have access to cutting edge treatments because our physicians and scientists are on the forefront of research in this critical area of medicine.
 
We invite you to get to know our faculty members better by taking the time to browse through their individual pages.  
 
Chief, Division of Hematology
Craig T. Jordan, PhD

 Results From Hematology : Selected site
PictureNameDescription

Blood Cancer & BMT Secondary - ​Pediatrics

Dr. Bernt is a physician-scientist who cares for children with leukemia and directs a laboratory research program studying leukemia biology and epigenetics.

Blood Cancer & BMT

Dr. Brewer leads the psychosocial team for the Bone Marrow Transplant program.  He works closely with Dr. Caspari to care for patients and families in the Blood Cancer Program.

Blood Cancer & BMT

Dr. Caspari is a member of the psychosocial team for the Bone Marrow Transplant program.  She works closely with Dr. Brewer to care for patients and families in the Blood Cancer Program.

Blood Cancer & BMT Secondary - Molecular Biology Program

Dr. Degregori is a leading expert in leukemia research and the Associate Director for Basic Science at the University of Colorado Cancer Center.

Blood Cancer & BMT Secondary - ​Pediatrics

Dr. Graham is a basic and translational researcher and Leader of Research Emphasis Area in the Biology of Childhood Cancer for Children’s Hospital Colorado (CHCO).  Dr. Graham is board-certified pediatric oncologist and an active member of the Leukemia/Lymphoma Team at CHCO.

Blood Cancer & BMT

Dr. Gutman directs the Allogeneic Bone Barrow Transplant (BMT) program and is a leading expert in the use of umbilical cord blood derived stem cells for BMT.  He oversees a broad range of clinical programs and trials.

Blood Cancer & BMT

Dr. Jordan serves as the Chief of the Hematology Division and directs a research program focused on the development of novel therapies for the treatment of leukemia.

​Blood Cancer & BMT Secondary - Pediatrics

Dr. Neff is a physician-scientist who cares for children with leukemia and directs a laboratory research program studying leukemia biology and epigenetics.

Blood Cancer & BMT

Dr. Nguyen is a physician-scientist who cares for adult patients with lymphoma and related blood diseases.  He also directs a laboratory program investigating the human microbiome and immunological issues related to graft vs host disease.

Blood Cancer & BMT

Dr. Pollyea is the Director of the adult Clinical Leukemia Program, and cares for patients with leukemia, myelodysplastic syndrome (MDS), and related diseases.  He leads multiple clinical trials to investigate new treatments for patients with blood cancer.

Blood Cancer & BMT Secondary - ​Pediatrics

Dr. Porter is a physician-scientist who cares for children with blood cancers and directs a laboratory research program focused on the development of new treatment modalities for blood cancer.

​Blood Cancer & BMT Secondary - Radiation Oncology

Dr. Rabinovitch is a professor of Radiation Oncology and works closely with the Hematology team to care for patients with various types of blood cancer.  She has been recognized multiple times as a 5280 magazine “Top Doctor.”

Blood Cancer & BMT

Dr. Smith is the Associate Chief of Hematology and the Clinical Director for the Blood Cancer Program.  He is a highly experienced laboratory researcher and directs a program focused on the development of new therapeutic regimens.